Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
18.6 USD | +4.00% | +5.57% | +70.61% |
05-10 | Wedbush Raises Edgewise Therapeutics' PT to $31 From $26, Keeps Outperform Rating | MT |
05-09 | Edgewise Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+70.61% | 1.67B | |
+61.32% | 55.07B | |
-1.87% | 41.79B | |
+44.36% | 40.22B | |
-8.29% | 28.17B | |
+12.24% | 26.28B | |
-20.96% | 18.93B | |
+6.87% | 13.03B | |
+28.44% | 12.26B | |
+26.09% | 12.21B |
- Stock Market
- Equities
- EWTX Stock
- News Edgewise Therapeutics, Inc.
- Truist Securities Starts Edgewise Therapeutics at Buy With $25 Price Target